Dexcare, a Washington based digitally-enabled healthcare platform, announced on 22nd March 2021 that it has raised US $ 20 million in its Series A round. The round was led by Define Ventures along with participation from Providence Ventures, Springrock Ventures, Frist Cressey Ventures and Kaiser Permanente Ventures.
Investors: Define Ventures is a California, United States, based venture capital firm that was founded in the year 2019 by Lynne Chou O’Keefe. It primarily focuses on early-stage digital healthcare companies that have the potential to redefine the healthcare system so as to bring a positive change in people’s lives. Its portfolio includes companies such as MedArrive, Storyhealth, Dawnlight, Folx, Lightship and more.
“DexCare’s unique solution to make digitally-enabled care more discoverable and actionable for consumers, while at the same time making it effective for health systems, is the kind of solution that will lead to a better healthcare system for everyone”—Lyne Chou O’Keefe, founder and managing partner of Define Ventures.
Dexcare was initially developed and incubated by Providence, one of the largest healthcare systems in the United States, as a platform for Providence’s ambulance care business. The current investment will help Dexcare come out as a separate company after having been incubated by Providence for 3-4 years.
Dexcare was founded in 2021 by Derek Streat and Sean O’Connor as a Platform-as-a-service offering to manage health system capacity and demand across all lines of care. It enables healthcare organisations to optimise their patient access that is aligned and balanced with their resources and operations.
Here’s how it works:-
Just as your computer’s operating system provides a seamless, connected and useful user experience, Dexcare provides core functions necessary to make digitally-enabled care efficient and effective.
Its service is a 4 step continuous cycle that involves intelligent navigation, capacity optimization, care continuity and demand generation.
To further understand how its system works, interested parties can book a demo on their official website
What the CEO has to say:
“We’re thrilled to see the incredible support for DexCare—from consumers, health systems and investors. Never before have consumers been faced with so many options for digitally-enabled care as health systems have invested in their digital capabilities in the wake of COVID-19. At the same time, the rise in the number of point solutions has led to a significant increase in complexity among the myriad offerings, as well as confusion for consumers. The need could not be greater for a rich platform that unifies consumer demand, health system resources and applications to make digital care truly work for all consumers and health systems”— Derek Streat, co-founder and CEO of Dexcare.
For more extensive analysis and Market Intelligence reports feel free to approach us or visit our website: Venture Capital Market Intelligence Reports | VCBay.
We try our best to fact check and bring the best, well-researched and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback and thank you for stopping by!